Literature DB >> 3783712

Deletion mutants that alter differential RNA processing in the E3 complex transcription unit of adenovirus.

B M Bhat, H A Brady, M H Pursley, W S Wold.   

Abstract

Region E3 of the adenovirus encodes about ten overlapping mRNAs (a to j) with different splicing patterns and with two RNA 3' end sites termed E3A and E3B. We have examined how deletions in 12 viable virus mutants affect differential RNA processing in E3. We assayed E3 mRNAs by the nuclease-gel and RNA blot procedures. Some deletions had no effect whereas others (e.g. deletion of a 3' splice or the E3A 3' end signal) had the anticipated effects on RNA processing. However, deletions in two regions had surprising effects. Deletions in one region (nucleotides 1691 to 2044) enhanced splicing at the upstream 951 5' splice site and the downstream 2157 and/or 2880 3' splice sites. Some of these deletions prevented RNA 3' end formation at the downstream E3A site. Deletion in the other region (nucleotides 2173 to 2237) enhanced an upstream splice site (951 to 2157) such that almost all pre-mRNA was processed into mRNA f. We suggest that these two regions contain cis-acting signals that regulate differential RNA processing. We discuss the results in terms of RNA folding and scanning models for splicing, as well as models for differential RNA 3' end formation at the E3A versus the E3B site.

Mesh:

Substances:

Year:  1986        PMID: 3783712     DOI: 10.1016/0022-2836(86)90240-8

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  17 in total

1.  Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus.

Authors:  H A Brady; A Scaria; W S Wold
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  The 11,600-MW protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection.

Authors:  A E Tollefson; A Scaria; S K Saha; W S Wold
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Genomic characterization of human adenovirus type 4 strains isolated worldwide since 1953 identifies two separable phylogroups evolving at different rates from their most recent common ancestor.

Authors:  Gabriel Gonzalez; Camden R Bair; Daryl M Lamson; Hidemi Watanabe; Laura Panto; Michael J Carr; Adriana E Kajon
Journal:  Virology       Date:  2019-09-08       Impact factor: 3.616

4.  The 5' and 3' splice sites come together via a three dimensional diffusion mechanism.

Authors:  Z Pasman; M A Garcia-Blanco
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

5.  Identification of a novel sequence that governs both polyadenylation and alternative splicing in region E3 of adenovirus.

Authors:  H A Brady; W S Wold
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

6.  A small deletion distant from a splice or polyadenylation site dramatically alters pre-mRNA processing in region E3 of adenovirus.

Authors:  B M Bhat; W S Wold
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

7.  Competition between splicing and polyadenylation reactions determines which adenovirus region E3 mRNAs are synthesized.

Authors:  H A Brady; W S Wold
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

8.  Multiple cis-acting sequence elements are required for efficient splicing of simian virus 40 small-t antigen pre-mRNA.

Authors:  X Y Fu; J D Colgan; J L Manley
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

9.  Upstream and downstream cis-acting elements for cleavage at the L4 polyadenylation site of adenovirus-2.

Authors:  A Sittler; H Gallinaro; M Jacob
Journal:  Nucleic Acids Res       Date:  1994-01-25       Impact factor: 16.971

10.  Role of early region 3 (E3) in pathogenesis of adenovirus disease.

Authors:  H S Ginsberg; U Lundholm-Beauchamp; R L Horswood; B Pernis; W S Wold; R M Chanock; G A Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.